| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -100,2 k € | -242.3% | -29,3 k € | -122.0% | 133,0 k € | +790.4% | 14,9 k € | -92.7% | 203,4 k € | -37.8% | 326,9 k € | +7.3% | 304,6 k € | +3.9% | 293,1 k € | -13.9% | 340,4 k € | +29.6% | 262,6 k € | -37.7% | 421,5 k € | |
| EBITDA | -101,1 k € | -232.5% | -30,4 k € | -123.1% | 131,7 k € | +839.7% | 14,0 k € | -93.1% | 202,6 k € | -37.7% | 325,3 k € | +7.3% | 303,3 k € | +14.3% | 265,5 k € | -11.2% | 298,9 k € | +26.4% | 236,5 k € | -32.4% | 350,1 k € | |
| Operating profit | -121,8 k € | -109.1% | -58,2 k € | -156.8% | 102,5 k € | +770.0% | -15,3 k € | -109.9% | 154,9 k € | -44.7% | 280,3 k € | +9.7% | 255,5 k € | +22.0% | 209,4 k € | -18.9% | 258,0 k € | +27.6% | 202,2 k € | -25.8% | 272,7 k € | |
| Profit/loss | -121,9 k € | -107.6% | -58,7 k € | -169.6% | 84,3 k € | +632.0% | -15,9 k € | -113.3% | 119,6 k € | -42.3% | 207,3 k € | +10.5% | 187,7 k € | +14.5% | 163,9 k € | -8.3% | 178,7 k € | +26.9% | 140,8 k € | -23.9% | 185,0 k € | |
| Equity | 92,3 k € | -56.9% | 214,2 k € | -21.5% | 272,9 k € | +44.7% | 188,6 k € | -7.8% | 204,5 k € | +141.0% | 84,8 k € | +9.4% | 77,6 k € | -58.5% | 186,9 k € | -64.3% | 523,0 k € | +51.9% | 344,3 k € | +69.1% | 203,6 k € | |
| Total assets | 122,9 k € | -44.1% | 219,8 k € | -27.6% | 303,4 k € | +38.1% | 219,7 k € | -12.1% | 249,9 k € | -26.2% | 338,4 k € | -16.0% | 403,0 k € | -50.0% | 805,8 k € | +23.4% | 652,9 k € | +56.4% | 417,4 k € | +34.3% | 310,9 k € | |
| Cash | 793,1 € | -99.2% | 105,6 k € | -42.0% | 182,0 k € | +204.9% | 59,7 k € | -34.2% | 90,7 k € | -41.0% | 153,8 k € | -13.5% | 177,8 k € | -65.6% | 516,1 k € | +7.5% | 480,0 k € | +42.7% | 336,3 k € | +70.0% | 197,9 k € | |
| Debts | 30,5 k € | +459.7% | 5,4 k € | -82.1% | 30,3 k € | -2.1% | 31,0 k € | -29.4% | 43,9 k € | -82.7% | 253,1 k € | -20.5% | 318,3 k € | -46.8% | 598,5 k € | +412.6% | 116,8 k € | +59.7% | 73,1 k € | -31.6% | 106,9 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | 0,9 | |||||||||||
Private limited company · Aarschot · incorporated on 19/03/2014
Private limited company loss-making in the latest fiscal year. Cash position declining (-99.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Johan Bellemans, orthopedie is a Private limited company incorporated in 2014. Its main activity is: Specialist medical practice activities. Its registered office is in Aarschot.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.